Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

ViiV Healthcare

- PMLiVE

GSK wins anthrax contract from US government

Signs $196m deal for its monoclonal anti-toxin raxibacumab

- PMLiVE

GSK antisense drug fails muscular dystrophy trial

Company and its partner Prosensa suffer setback with drisapersen

- PMLiVE

EMA backs drugs from Novo, Otsuka, AZ, Janssen, GSK

Nine new branded medicines recommended for use in Europe

- PMLiVE

Double asthma approval in Japan lifts SkyePharma

Regulatory wins for company’s commercial partners GSK and Kyorin

- PMLiVE

GSK hands back rights to ChemoCentryx drug

Investigational IBD treatment vercirnon disappoints in phase III

- PMLiVE

FDA guidance clears path for Advair generics

Offers simplified process for potential copies of GSK’s asthma and COPD drug

- PMLiVE

US turns spotlight on GSK bribery allegations

Department of Justice to investigate whether pharma giant contravened foreign corruption act

- PMLiVE

FDA queries safety of GSK’s Anoro for COPD

Adviser questions the drug's cardiovascular profile

- PMLiVE

GSK sells Lucozade and Ribena for £1.35bn

Suntory Beverage & Food acquires consumer brands

- PMLiVE

Setback for GSK as melanoma vaccine misses targets

Cancer immunotherapy disappoints in phase III

- PMLiVE

GSK splits media account between two agencies

GroupM and Omnicom are the winners in GSK’s latest consolidation

China flag thumb

GSK blamed for employee bribes in China

Xinhua news agency claims company was complicit in the payment of kickbacks to doctors

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links